Philip Chepsy, David Alice, Mathew S K, Sunny Sanjo, Kumar K Vijaya, Jacob Linda, Mathew Luke, Kumar Suresh, Chandy George
Clinical Hematology and Bone Marrow Transplant, COVID-19 Research Group, Believers Church Medical College Hospital, Thiruvalla, IND.
Medical Research, COVID-19 Research Group, Believers Church Medical College Hospital, Thiruvalla, IND.
Cureus. 2022 Oct 17;14(10):e30373. doi: 10.7759/cureus.30373. eCollection 2022 Oct.
Background and aims The second wave of coronavirus disease 2019 (COVID-19) has been devastating in India and many developing countries. The mortality reported has been 40% higher than in the first wave, overwhelming the nation's health infrastructure. Despite a better understanding of the disease and established treatment protocols including steroids and heparin, the second wave was disastrous. Subsequent waves have the potential to further cripple healthcare deliveries, also affecting non-COVID-19 care across many developing economies. It is then important to identify and triage high-risk patients to best use the limited resources. Routine tests such as neutrophil and monocyte counts have been identified but have not been successfully validated uniformly, and their utility is still being understood in COVID-19. Various predictive models that are available require online resources and calculators and additionally await validation across all populations. These, although useful, might not be available or accessible across all institutions. It is then important to identify easy-to-use scores that utilize tests done routinely. In identifying with this goal, we did a retrospective review of the institutional database to identify potential predictors of intensive care unit (ICU) admission and mortality in patients hospitalized during the second wave who accessed healthcare at our academic setup. Results Three predictors of mortality and four predictors of ICU admission were identified. Absolute neutrophil count was a common predictor of both ICU admission and mortality but with two separate cut points. An absolute neutrophil count of >4,200 predicted need for ICU admission (odds ratio (OR): 3.1 (95% confidence interval (CI): 2.0, 4.8)), and >7,200 predicted mortality (adjusted OR: 4.2 (95% CI: 1.9, 9.4)). We observed that a blood urea level greater than 45 was predictive of needing ICU care (adjusted OR: 8.0 (95% CI: 3.7, 17.6)). In our dataset, serum ferritin of >500 was predictive of ICU admission (adjusted OR: 2.7 (95% CI: 1.2, 5.9)). We noted a right shift of partial pressure (p50 is the oxygen tension at which hemoglobin is 50% saturated) (p50c) in SARS-CoV-2 as a predictor of ICU care (OR: 2.6 (95% CI: 1.7, 3.9)) when partial pressure is >26.5. In our analysis, a serum protein of less than 7 g/dL (OR: 2.8 (95% CI: 1.7, 4.4)) was a predictive variable for ICU admission. An LDH value of >675 was predictive of severity with a need for ICU admission (OR: 9.2 (95% CI: 5.4, 15.5)) in our series. We then assigned a score to each of the predictive variables based on the adjusted odds ratio. Conclusion We identified a set of easy-to-use predictive variables and scores to recognize the subset of patients hospitalized with COVID-19 with the highest risk of death or clinical worsening requiring ICU care.
背景与目的 2019年冠状病毒病(COVID-19)的第二波疫情在印度和许多发展中国家造成了毁灭性影响。报告的死亡率比第一波高出40%,使该国的卫生基础设施不堪重负。尽管对该疾病有了更好的了解,并制定了包括使用类固醇和肝素在内的既定治疗方案,但第二波疫情仍是灾难性的。后续疫情有可能进一步削弱医疗服务,也会影响许多发展中经济体的非COVID-19医疗服务。因此,识别和分诊高危患者以最佳利用有限资源非常重要。诸如中性粒细胞和单核细胞计数等常规检测方法已被确定,但尚未得到统一成功验证,其在COVID-19中的效用仍在研究中。现有的各种预测模型需要在线资源和计算器,此外还需在所有人群中进行验证。这些模型虽然有用,但可能并非所有机构都能获取或使用。因此,识别易于使用且利用常规检测的评分很重要。为实现这一目标,我们对机构数据库进行了回顾性分析,以确定在我们学术机构接受医疗服务的第二波疫情期间住院患者入住重症监护病房(ICU)和死亡的潜在预测因素。结果 确定了三个死亡预测因素和四个ICU入住预测因素。绝对中性粒细胞计数是ICU入住和死亡的共同预测因素,但有两个不同的切点。绝对中性粒细胞计数>4200预测需要入住ICU(比值比(OR):3.1(95%置信区间(CI):2.0,4.8)),>7200预测死亡(调整后OR:4.2(95%CI:1.9,9.4))。我们观察到血尿素水平大于45可预测需要ICU护理(调整后OR:8.0(95%CI:3.7,17.6))。在我们的数据集中,血清铁蛋白>500可预测ICU入住(调整后OR:2.7(95%CI:1.2,5.9))。当分压>26.5时,我们注意到严重急性呼吸综合征冠状病毒2(SARS-CoV-2)中氧分压(p50是血红蛋白饱和度为50%时的氧张力)(p50c)右移可作为ICU护理的预测因素(OR:2.6(95%CI:1.7,3.9))。在我们的分析中,血清蛋白<7 g/dL(OR:2.8(95%CI:1.7,4.4))是ICU入住的预测变量。在我们的系列研究中,乳酸脱氢酶(LDH)值>675可预测病情严重程度且需要入住ICU(OR:9.2(95%CI:5.4,15.5))。然后我们根据调整后的比值比对每个预测变量进行评分。结论 我们确定了一组易于使用的预测变量和评分,以识别COVID-19住院患者中死亡风险或临床恶化需要ICU护理风险最高的亚组。